Tolerance Bio will increase health span by preserving, restoring, AND MANIPULATING the function of the thymus, the master regulator of immune tolerance News & UPDATES Featured Oct 15, 2024 Tolerance Bio, Inc. Launches with $17.2 Million in Seed Financing to Advance Thymus-Based Therapies for Immune-Mediated Diseases Oct 15, 2024 Read More → Oct 15, 2024
